Commerce Bank purchased a new position in shares of Danaher Corporation (NYSE:DHR – Free Report) during the 2nd quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission. The fund purchased 193,732 shares of the conglomerate’s stock, valued at approximately $36,902,000.
A number of other institutional investors and hedge funds have also recently bought and sold shares of DHR. Main Street Group LTD purchased a new stake in shares of Danaher during the first quarter valued at approximately $25,000. N.E.W. Advisory Services LLC purchased a new position in shares of Danaher in the second quarter valued at $25,000. JPL Wealth Management LLC purchased a new position in shares of Danaher in the third quarter valued at $25,000. WFA of San Diego LLC acquired a new stake in Danaher during the 2nd quarter valued at $26,000. Finally, Hilton Head Capital Partners LLC purchased a new stake in Danaher during the 4th quarter worth $27,000. Hedge funds and other institutional investors own 79.05% of the company’s stock.
Danaher Price Performance
Shares of DHR stock opened at $219.42 on Friday. The firm has a fifty day moving average of $195.80 and a two-hundred day moving average of $192.61. The firm has a market cap of $154.25 billion, a P/E ratio of 38.97, a P/E/G ratio of 2.72 and a beta of 0.78. Danaher Corporation has a 1-year low of $160.93 and a 1-year high of $242.80. The company has a debt-to-equity ratio of 0.48, a current ratio of 1.65 and a quick ratio of 1.25.
Wall Street Analyst Weigh In
DHR has been the topic of a number of recent analyst reports. Piper Sandler started coverage on shares of Danaher in a report on Thursday, June 11th. They issued a “neutral” rating and a $200.00 price objective on the stock. HSBC lowered their target price on Danaher from $270.00 to $230.00 and set a “buy” rating for the company in a research note on Wednesday, June 3rd. Stifel Nicolaus dropped their target price on Danaher from $260.00 to $220.00 and set a “buy” rating on the stock in a research report on Wednesday, July 22nd. Deutsche Bank Aktiengesellschaft reiterated a “buy” rating and issued a $240.00 price target on shares of Danaher in a research note on Wednesday, July 22nd. Finally, Weiss Ratings raised Danaher from a “sell (d+)” rating to a “hold (c-)” rating in a report on Wednesday, July 15th. One investment analyst has rated the stock with a Strong Buy rating, nineteen have assigned a Buy rating and five have assigned a Hold rating to the stock. According to data from MarketBeat.com, the stock has an average rating of “Moderate Buy” and an average price target of $228.91.
Get Our Latest Stock Analysis on Danaher
Danaher Company Profile
Danaher Corporation (NYSE: DHR) is a global science and technology company that designs, manufactures and markets products and services for the life sciences, diagnostics, and environmental and applied markets. The company organizes its operations into business segments focused on Life Sciences, Diagnostics, and Environmental & Applied Solutions, supplying instruments, reagents, software and related services that support research, clinical testing, biopharmaceutical development, and industrial and environmental monitoring.
Products and services in Danaher’s portfolio include analytical and diagnostic instruments, laboratory consumables and reagents, digital and software solutions for workflow and data management, field and industrial monitoring equipment, and service and maintenance programs.
See Also
- Five stocks we like better than Danaher
- 2 Biotech Stocks Shaping Up for Major Breakouts
- 3 Stocks Came Roaring Back—Now They’re Flashing Warning Signs
- 3 Beaten-Down Stocks That Haven’t Gotten the Message About the S&P 500’s Record Run
- Darden Restaurants Just Hit a 52-Week High–Is the Olive Garden Comeback Story Legit?
Want to see what other hedge funds are holding DHR? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Danaher Corporation (NYSE:DHR – Free Report).
Receive News & Ratings for Danaher Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Danaher and related companies with MarketBeat.com's FREE daily email newsletter.
